AI Science Tracker

Active learning selected antimicrobial polymer P7

Zhejiang University; Institute of Intelligent Chemical Manufacturing and iChemFoundry Platform, Zhejiang University · 17 Dec 2025 · materials

Discovery

Active learning selected antimicrobial polymer P7

An automated Design-Build-Test-Learn campaign applied machine learning and high-throughput synthesis/characterization to a library of 13,728 polymer combinations. Across four active-learning rounds, the authors selected seven candidates for detailed testing. The leading polymer P7 had a reported MIC of 2 μg/mL and IC20 of 256 μg/mL, and was tested in in-vitro and animal models. These laboratory and preclinical results do not establish clinical efficacy or safety.

Technology: Graph Transformer model with active-learning selection

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The study reports seven top candidates from four active-learning rounds. P7 had MIC 2 μg/mL and IC20 256 μg/mL, with in-vitro characterization and animal-model testing reported by the authors.
  • Still unknown: These are laboratory and animal results, not human efficacy or safety. The entry reports the authors’ selection and assay result without a claim of global chemical novelty or clinical readiness.
  • AI role: A graph-transformer prediction model and active-learning loop ranked polymer candidates for automated synthesis and antimicrobial/biocompatibility testing.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12769852/ · https://pubmed.ncbi.nlm.nih.gov/41502979/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 17 Nov 2026. Review scope: Primary PMC indexed full text and NCBI/PubMed metadata/abstract for publication date, affiliations, model, assay outcomes and P7 result..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.